Cefixime 100mg/5ml Dry Syrup Franchise in Ahmedabad

Cefixime 100mg/5ml Dry Syrup Supplier in Mumbai

Cefixime 100mg/5ml Dry Syrup Distributor in Delhi

Cefixime 100mg/5ml Dry Syrup Franchise Opportunity in Bangalore

Cefixime 100mg/5ml Dry Syrup Stockist in Hyderabad
Cefixime 100mg/5ml Dry Syrup Export & Manufacturing in Chandigarh

Home/Products /cefixime-10mg-5ml

Cefzlora 100 Dry Syrup

Composition : Cefixime (100mg/5ml) Dry Syrup

Dosage Form : Dry Syrup

Packaging Type : HDPE +WATER

Packaging : 30 ml

Price : ₹76/-

Contact For Business Query

Cefzlora 100 Dry Syrup contains Cefixime 100mg/5ml, a third-generation cephalosporin antibiotic indicated for the treatment of pediatric bacterial infections. It helps manage infections of the respiratory tract, ENT, urinary tract, and skin, providing effective relief and recovery in children.

Cefixime works by inhibiting bacterial cell wall synthesis, leading to elimination of susceptible bacteria. Its broad-spectrum activity and palatable dry syrup formulation ensure accurate pediatric dosing and high compliance.

This formulation is recommended by pediatricians for mild to moderate bacterial infections and ensures precise, reliable dosing. Cefzlora 100 Dry Syrup is a high-demand pediatric antibiotic across hospitals, clinics, and public health programs.

Adding Cefzlora 100 Dry Syrup to your pediatric antibiotic segment strengthens your portfolio with a trusted cephalosporin therapy. Its prescriber preference, consistent demand, and applicability for domestic and export markets make it a valuable addition to pharmaceutical distribution portfolios.

Read More

About the Product

Cefzlora 100 Dry Syrup contains Cefixime 100mg/5ml, a third-generation cephalosporin antibiotic indicated for the treatment of pediatric bacterial infections. It helps manage infections of the respiratory tract, ENT, urinary tract, and skin, providing effective relief and recovery in children.

Cefixime works by inhibiting bacterial cell wall synthesis, leading to elimination of susceptible bacteria. Its broad-spectrum activity and palatable dry syrup formulation ensure accurate pediatric dosing and high compliance.

This formulation is recommended by pediatricians for mild to moderate bacterial infections and ensures precise, reliable dosing. Cefzlora 100 Dry Syrup is a high-demand pediatric antibiotic across hospitals, clinics, and public health programs.

Adding Cefzlora 100 Dry Syrup to your pediatric antibiotic segment strengthens your portfolio with a trusted cephalosporin therapy. Its prescriber preference, consistent demand, and applicability for domestic and export markets make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include diarrhea, nausea, vomiting, abdominal discomfort, or mild skin rash. Rare but serious side effects include severe allergic reactions, Clostridioides difficile–associated diarrhea, liver function abnormalities, or changes in blood counts. Patients should seek immediate medical attention if severe or unusual symptoms occur.

Cefzlora 100 Dry Syrup is indicated for the treatment of respiratory tract infections, urinary tract infections, otitis media, pharyngitis, tonsillitis, and other infections caused by susceptible bacteria, as prescribed by a healthcare professional.

Cefzlora 100 Dry Syrup should be used exactly as prescribed, and the full course must be completed to prevent antibiotic resistance. Shake well before each dose and use the provided measuring device. Inform the doctor if the patient has a history of allergy to cephalosporins or penicillins.

Store the unreconstituted powder in a cool, dry place away from moisture. After reconstitution, store the syrup as directed on the label, usually under refrigeration, and use within the specified time. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation

@2024 | copy rights by Cafoli